Innogen's Remarkable Trading Debut in Hong Kong
Guangzhou Innogen Pharmaceutical Group, a Chinese biotech firm, saw its shares soar by 296% on its trading debut in Hong Kong, marking the best first-day performance among 54 companies this year. The company aims to penetrate the obesity drug market, with CEO Qinghua Wang discussing its potential on Bloomberg.
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
4,251
189
191
2 hours ago
Mobile App
Available on iOS & AndroidThe mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
4,251
189
191
2 hours ago
Mobile App
Available on iOS & AndroidThe mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more